Psychosomatic Medicine, Vol 54, Issue 5 588-601, Copyright © 1992 by American Psychosomatic Society

ORIGINAL ARTICLES

Prevalence of psychiatric disorders in early stages of HIV infection

GR Brown, JR Rundell, SE McManis, SN Kendall, R Zachary and L Temoshok
Henry M. Jackson Foundation, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas.

As part of a military universal HIV screening program, 442 men were assessed for the presence of DSM-III-R defined psychiatric disorders and symptoms of anxiety and depression after notification of HIV seroconversion. Of them, 84.4% were in the earliest, asymptomatic stages of disease at the time of interview (96% did not have AIDS). The Structured Clinical Interview for DSM-III-R and Structured Interview Guide for the Hamilton Anxiety and Depression Scales were used. Relevant comparisons were made to Epidemiologic Catchment Area prevalence data. HIV seropositive men were more likely than age-matched men in the community to have current diagnoses of major depression (ages 18-44) and anxiety disorders (ages 25-44). Higher lifetime rates of major depression and alcohol use disorder, and high current prevalence of sexual dysfunction (21.7%) were noted. We conclude that men who become HIV seropositive have high rates of mood and substance use disorders prior to knowledge of seroconversion, and that early in the course of HIV infection men are at risk for developing major depression, anxiety disorders, and disorders of sexual desire.

This article has been cited by other articles:

				M. Cohen, R. G. Hoffman, C. Cromwell, J. Schmeidler, F. Ebrahim, G. Carrera, F. Endorf, C. A. Alfonso, and J. M. Jacobson The Prevalence of Distress in Persons With Human Immunodeficiency Virus Infection Psychosomatics, February 1, 2002; 43(1): 10 - 15. [Abstract] [Full Text]

				E. G. Bing, M. A. Burnam, D. Longshore, J. A. Fleishman, C. D. Sherbourne, A. S. London, B. J. Turner, F. Eggan, R. Beckman, B. Vitiello, et al. Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus-Infected Adults in the United States Arch Gen Psychiatry, August 1, 2001; 58(8): 721 - 728. [Abstract] [Full Text] [PDF]

				M. A. Burnam, E. G. Bing, S. C. Morton, C. Sherbourne, J. A. Fleishman, A. S. London, B. Vitiello, M. Stein, S. A. Bozzette, and M. F. Shapiro Use of Mental Health and Substance Abuse Treatment Services Among Adults With HIV in the United States Arch Gen Psychiatry, August 1, 2001; 58(8): 729 - 736. [Abstract] [Full Text] [PDF]

				C. D. Sherbourne, R. D. Hays, J. A. Fleishman, B. Vitiello, K. M. Magruder, E. G. Bing, D. McCaffrey, A. Burnam, D. Longshore, F. Eggan, et al. Impact of Psychiatric Conditions on Health-Related Quality of Life in Persons With HIV Infection Am J Psychiatry, February 1, 2000; 157(2): 248 - 254. [Abstract] [Full Text]

				A. J. Elliott, K. K. Uldall, K. Bergam, J. Russo, K. Claypoole, and P. P. Roy-Byrne Randomized, Placebo-Controlled Trial of Paroxetine Versus Imipramine in Depressed HIV-Positive Outpatients Am J Psychiatry, March 1, 1998; 155(3): 367 - 372. [Abstract] [Full Text]